La biotechnologie ouverte - Bilan de la rencontre de deux révolutions

Yann Joly

doi:doi:10.1051/medsci/20092511957

Accès gratuit

Numéro		Med Sci (Paris) Volume 25, Numéro 11, Novembre 2009


Page(s)		957 - 962
Section		Forum
DOI		http://dx.doi.org/10.1051/medsci/20092511957
Publié en ligne		15 November 2009

Nuvolari A. Open source software development: some historical perspectives. First Monday 2005; 10 : 10.
Raymond ES. The cathedral and the bazaar: musings on Linux and open source by an accidental revolutionary. Sebastopol : O’Reilly Media, 2001 : 242 p.
Stallman RM. Free software, free society: selected essays of Richard M. Stallman. Boston : Free Software Foundation, 2002 : 224 p.
Guadamuz A. Viral contracts or unenforceable documents ? Contractual validity of copyleft licenses. EIPR 2004; 26 : 8.
Free Standard Group, The imperative for Linux standards: a recommendation for the future. San Francisco : Free Standard Group, 2005 : 14 p.
Haskins W. Linux ecosystem revenue to near $50 billion by 2011 (Linux Insider, 04/10/08) http://www.linuxinsider.com/story/Linux-Ecosystem-Revenue-to-Near-50-Billion-by-2011-62539.html
Feldman RC. The open source biotechnology movement: is it patent misuse ? Minn JL Sci Tech 2004; 6 : 117.
Rai AK. Open and collaborative research: a new model for biomedicine. In : Hahn RW, ed. Intellectual property rights in frontier industries. Washington DC : AEI-Brookings Press, 2005 : 131–58.
Benkler Y. The wealth of networks: how social production transforms markets and freedom. New Haven : Yale University Press, 2006 : 528 p.
Merges RP. Colloquium: a new dynamism in the public domain. U Chi L Rev 2004; 71 : 183.
Nicol D, Hope JE. Cooperative strategies for facilitating use of patented inventions in biotechnology. Law Context 2006; 24 : 1.
Science Commons. Empirical data about materials transfer problems. Cambridge : Science Commons, 2008 (en ligne). http://sciencecommons.org/projects/licensing/empirical-data-about-materials-transfer/.
Lee GK, Cole RE. From a firm based to a community-based model of knowledge creation: the case of the Linux Kernel development. Org Sci 2003; 14 : 633.
Niman NB, Kench BT. Open source in the pharmaceutical industry. Proc Mw Bus Econ Ass’n 2003; 124.
Dalle JM, David PM. The allocation of software development resources in open source production mode. Stanford: The Stanford Institute for Economic and Policy Research, 2003 : 40 p.
Lerner J, Tirole J. The economics of technology sharing: open source and beyond. J Econ Persp 2005; 19 : 99.
Von Hippel E. Horizontal innovation networks by and for users. Advance access published online on May 16, 2007, Industrial and Corporate Change 10.
Lerner J, Tirole J. The simple economics of open source. Cambridge : National Bureau of Economic Research, 2000 : 26.
Hope J. Open source biotechnology: a new way to manage scientific intellectual property. GeneWatch 2005; 18 :1.
Eco-Patent Commons, Eco-patent commons brochure 2008 en ligne : http://sustainable-finance.org/DocRoot/4tF7aXkIt0vZODBJobYY/Eco-Patent%20Commons%20Brochure_011008.pdf
Eisenberg RS. Will pharmacogenomics alter the role of patents in drug development ? Pharmacogenomics 2002; 3 : 571.
Thorisson GA, Stein LD. The SNP consortium website: past, present and future. Nucleic Acids Res 2003; 31 :1.
deCode genetics, Inc. Annual report pursuant to section 13 or 15(d) of the securities exchange act of 1934 (2007) en ligne : http://www.sec.gov/Archives/edgar/data/1022974/000110465907019321/a07-5795_110k.htm
NIH News, International HapMap Widens Data Access 2004 en ligne : http://www.nih.gov/news/pr/dec2004/nhgri-10.htm
Thorisson GA, Smith AV, Krishnan L, Stein LD. The international HapMap project web site. Genome Res 2005; 15 : 1592.

[1] Nuvolari A. Open source software development: some historical perspectives. First Monday 2005; 10 : 10.

[2] Raymond ES. The cathedral and the bazaar: musings on Linux and open source by an accidental revolutionary. Sebastopol : O’Reilly Media, 2001 : 242 p.

[3] Stallman RM. Free software, free society: selected essays of Richard M. Stallman. Boston : Free Software Foundation, 2002 : 224 p.

[4] Guadamuz A. Viral contracts or unenforceable documents ? Contractual validity of copyleft licenses. EIPR 2004; 26 : 8.

[5] Free Standard Group, The imperative for Linux standards: a recommendation for the future. San Francisco : Free Standard Group, 2005 : 14 p.

[6] Haskins W. Linux ecosystem revenue to near $50 billion by 2011 (Linux Insider, 04/10/08) http://www.linuxinsider.com/story/Linux-Ecosystem-Revenue-to-Near-50-Billion-by-2011-62539.html

[7] Feldman RC. The open source biotechnology movement: is it patent misuse ? Minn JL Sci Tech 2004; 6 : 117.

[8] Rai AK. Open and collaborative research: a new model for biomedicine. In : Hahn RW, ed. Intellectual property rights in frontier industries. Washington DC : AEI-Brookings Press, 2005 : 131–58.

[9] Benkler Y. The wealth of networks: how social production transforms markets and freedom. New Haven : Yale University Press, 2006 : 528 p.

[10] Merges RP. Colloquium: a new dynamism in the public domain. U Chi L Rev 2004; 71 : 183.

[11] Nicol D, Hope JE. Cooperative strategies for facilitating use of patented inventions in biotechnology. Law Context 2006; 24 : 1.

[12] Science Commons. Empirical data about materials transfer problems. Cambridge : Science Commons, 2008 (en ligne). http://sciencecommons.org/projects/licensing/empirical-data-about-materials-transfer/.

[13] Lee GK, Cole RE. From a firm based to a community-based model of knowledge creation: the case of the Linux Kernel development. Org Sci 2003; 14 : 633.

[14] Niman NB, Kench BT. Open source in the pharmaceutical industry. Proc Mw Bus Econ Ass’n 2003; 124.

[15] Dalle JM, David PM. The allocation of software development resources in open source production mode. Stanford: The Stanford Institute for Economic and Policy Research, 2003 : 40 p.

[16] Lerner J, Tirole J. The economics of technology sharing: open source and beyond. J Econ Persp 2005; 19 : 99.

[17] Von Hippel E. Horizontal innovation networks by and for users. Advance access published online on May 16, 2007, Industrial and Corporate Change 10.

[18] Lerner J, Tirole J. The simple economics of open source. Cambridge : National Bureau of Economic Research, 2000 : 26.

[19] Hope J. Open source biotechnology: a new way to manage scientific intellectual property. GeneWatch 2005; 18 :1.

[20] Eco-Patent Commons, Eco-patent commons brochure 2008 en ligne : http://sustainable-finance.org/DocRoot/4tF7aXkIt0vZODBJobYY/Eco-Patent%20Commons%20Brochure_011008.pdf

[21] Eisenberg RS. Will pharmacogenomics alter the role of patents in drug development ? Pharmacogenomics 2002; 3 : 571.

[22] Thorisson GA, Stein LD. The SNP consortium website: past, present and future. Nucleic Acids Res 2003; 31 :1.

[23] deCode genetics, Inc. Annual report pursuant to section 13 or 15(d) of the securities exchange act of 1934 (2007) en ligne : http://www.sec.gov/Archives/edgar/data/1022974/000110465907019321/a07-5795_110k.htm

[24] NIH News, International HapMap Widens Data Access 2004 en ligne : http://www.nih.gov/news/pr/dec2004/nhgri-10.htm

[25] Thorisson GA, Smith AV, Krishnan L, Stein LD. The international HapMap project web site. Genome Res 2005; 15 : 1592.

Prix Nobel 2012